Congenital membranous nephropathy due to fetomaternal anti-neutral endopeptidase alloimmunization

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:69063P96.0
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Congenital membranous nephropathy due to fetomaternal anti-neutral endopeptidase (NEP) alloimmunization is a very rare kidney disease that affects newborn babies. It is sometimes called NEP alloimmunization nephropathy or anti-NEP congenital nephrotic syndrome. The condition happens when a mother's immune system makes antibodies against a protein called neutral endopeptidase (NEP), which is found on the surface of kidney cells. This can occur when the mother herself naturally lacks the NEP protein (due to changes in her own genes) and her immune system sees the baby's NEP protein as foreign. During pregnancy, these maternal antibodies cross the placenta and attack the baby's kidney cells, causing damage to the tiny filtering units of the kidneys called glomeruli. The kidney damage leads to a condition called nephrotic syndrome in the newborn. This means the kidneys leak large amounts of protein into the urine, causing the baby to have low protein levels in the blood and significant swelling (edema), especially in the face, belly, and legs. Affected babies may also have difficulty breathing due to fluid buildup and may show signs of poor kidney function from birth or shortly after. Treatment focuses on managing the symptoms of nephrotic syndrome, supporting kidney function, and removing the harmful maternal antibodies from the baby's blood. Many affected babies improve over time as the maternal antibodies naturally clear from their system, though some may experience lasting kidney damage. Early diagnosis and careful medical management are essential for the best possible outcome.

Also known as:

Key symptoms:

Severe swelling (edema) of the face, belly, and legs in a newbornLarge amounts of protein leaking into the urine (proteinuria)Low protein levels in the blood (hypoalbuminemia)Fluid buildup in the belly (ascites)Difficulty breathing due to fluid around the lungsPoor urine output or signs of kidney failurePale or puffy appearance at birthHigh cholesterol levels in the bloodPoor feeding and weight gain problemsIncreased risk of infections due to low immune proteins

Clinical phenotype terms (5)— hover any for plain English
Glomerular depositsHP:0030949Pregnancy exposureHP:0031437
Inheritance

Sporadic

Usually appears on its own, not inherited from a parent

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Congenital membranous nephropathy due to fetomaternal anti-neutral endopeptidase alloimmunization.

View clinical trials →

No actively recruiting trials found for Congenital membranous nephropathy due to fetomaternal anti-neutral endopeptidase alloimmunization at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Congenital membranous nephropathy due to fetomaternal anti-neutral endopeptidase alloimmunization community →

No specialists are currently listed for Congenital membranous nephropathy due to fetomaternal anti-neutral endopeptidase alloimmunization.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Congenital membranous nephropathy due to fetomaternal anti-neutral endopeptidase alloimmunization.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Congenital membranous nephropathy due to fetomaternal anti-neutral endopeptidase alloimmunizationForum →

No community posts yet. Be the first to share your experience with Congenital membranous nephropathy due to fetomaternal anti-neutral endopeptidase alloimmunization.

Start the conversation →

Latest news about Congenital membranous nephropathy due to fetomaternal anti-neutral endopeptidase alloimmunization

No recent news articles for Congenital membranous nephropathy due to fetomaternal anti-neutral endopeptidase alloimmunization.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Questions for your doctor

Bring these to your next appointment

  • Q1.How severe is my baby's kidney damage, and what is the expected recovery timeline?,What signs of worsening should I watch for at home, and when should I go to the emergency room?,Does my baby need any special diet or fluid restrictions?,What is the risk that this will happen again in a future pregnancy, and how can we reduce that risk?,Should our whole family have genetic testing, and what does a positive MME gene result mean for me and my relatives?,Will my child need long-term kidney medications or monitoring, and what does that look like?,Are there any specialists or centers with specific experience in this condition that you would recommend?

Common questions about Congenital membranous nephropathy due to fetomaternal anti-neutral endopeptidase alloimmunization

What is Congenital membranous nephropathy due to fetomaternal anti-neutral endopeptidase alloimmunization?

Congenital membranous nephropathy due to fetomaternal anti-neutral endopeptidase (NEP) alloimmunization is a very rare kidney disease that affects newborn babies. It is sometimes called NEP alloimmunization nephropathy or anti-NEP congenital nephrotic syndrome. The condition happens when a mother's immune system makes antibodies against a protein called neutral endopeptidase (NEP), which is found on the surface of kidney cells. This can occur when the mother herself naturally lacks the NEP protein (due to changes in her own genes) and her immune system sees the baby's NEP protein as foreign. D

How is Congenital membranous nephropathy due to fetomaternal anti-neutral endopeptidase alloimmunization inherited?

Congenital membranous nephropathy due to fetomaternal anti-neutral endopeptidase alloimmunization follows a sporadic inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Congenital membranous nephropathy due to fetomaternal anti-neutral endopeptidase alloimmunization typically begin?

Typical onset of Congenital membranous nephropathy due to fetomaternal anti-neutral endopeptidase alloimmunization is neonatal. Age of onset can vary across affected individuals.